跳到正文
原文
Endpoints News 生物医药· John Carroll·· 28 天前AI 评分26

第三季度生物医药行业受并购放缓影响承压

Biotech takes a hit as dealmakers take a knee in Q3

AI 导读

第三季度生物医药行业因并购活动放缓而面临冲击,此前上半年行业M&A交易热潮的势头明显降温。

正文

A chill wind blew through the bio­phar­ma in­dus­try in the third quar­ter as the pace of M&A from the first half of the year cooled …

Endpoints Premium

This article is available only to Premium subscribers

Upgrade to Premium for unlimited access and Premium exclusives.

来源:Endpoints News 生物医药 · endpoints.news